Expression mediated by three partial sequences of the human tyrosine hydroxylase promoter in vivo

1Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The use of viral vectors to transfect postmitotic neurons has provided an important research tool, and it offers promise for treatment of neurologic disease. The utility of vectors is enhanced by the use of selective promoters that permit control of the cellular site of expression. One potential clinical application is in the neurorestorative treatment of Parkinson's disease by the induction of new axon growth. However, many of the genes with an ability to restore axons have oncogenic potential. Therefore, clinical safety would be enhanced by restriction of expression to neurons affected by the disease, particularly dopamine neurons. To achieve this goal we have evaluated in vivo three partial sequences of the promoter for human tyrosine hydroxylase, the rate limiting enzyme in catecholamine synthesis. All sequences induced expression in dopamine neurons. None of them induced expression in glia or in nondopaminergic neurons in striatum or cortex. We conclude that these sequences have potential use for targeting dopamine neurons in research and clinical applications.

Cite

CITATION STYLE

APA

Rolland, A. S., Kareva, T., Yarygina, O., Kholodilov, N., & Burke, R. E. (2016). Expression mediated by three partial sequences of the human tyrosine hydroxylase promoter in vivo. Molecular Therapy Methods and Clinical Development, 3, 16062. https://doi.org/10.1038/mtm.2016.62

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free